메뉴 건너뛰기




Volumn , Issue , 2013, Pages

Designing a digital patient avatar in the context of the MyHealthAvatar project initiative

Author keywords

[No Author keywords available]

Indexed keywords


EID: 84894209926     PISSN: None     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1109/BIBE.2013.6701560     Document Type: Conference Paper
Times cited : (18)

References (19)
  • 1
    • 84894191167 scopus 로고    scopus 로고
    • Available
    • Migration Information Source, Available: http://www.migrationinformation. org/feature/display.cfm?ID=402
  • 3
    • 84894165672 scopus 로고    scopus 로고
    • Available
    • VPH-SHARE, Available: http://www.vph-share.eu/
  • 7
    • 84894118181 scopus 로고    scopus 로고
    • http://www-03.ibm.com/press/us/en/pressrelease/22375.wss
  • 8
    • 84894177620 scopus 로고    scopus 로고
    • Available
    • HealthVault, Available: https://www.healthvault.com/gr/en
  • 9
    • 70350381719 scopus 로고    scopus 로고
    • Available
    • Google Health, Available: http://en.wikipedia.org/wiki/Google-Health
    • Google Health
  • 10
    • 84894148078 scopus 로고    scopus 로고
    • Available
    • Zygote Body, Available: http://www.zygotebody.com/
  • 12
  • 13
    • 67649392513 scopus 로고    scopus 로고
    • A framework for assessing inter-individual variability in pharmacokinetics using virtual human populations and integrating general knowledge of physical chemistry, biology, anatomy, physiology and genetics: A tale of 'bottom-up' vs 'top-down' recognition of covariates
    • M. Jamei, G. L. Dickinson, and A. Rostami-Hodjegan, "A framework for assessing inter-individual variability in pharmacokinetics using virtual human populations and integrating general knowledge of physical chemistry, biology, anatomy, physiology and genetics: A tale of 'bottom-up' vs 'top-down' recognition of covariates", Drug Metab Pharmacokinet, vol. 24, 2009, pp. 53-75.
    • (2009) Drug Metab Pharmacokinet , vol.24 , pp. 53-75
    • Jamei, M.1    Dickinson, G.L.2    Rostami-Hodjegan, A.3
  • 14
    • 13244287685 scopus 로고    scopus 로고
    • 'In silico' simulations to assess the 'in vivo' consequences of 'in vitro' metabolic drug-drug interactions
    • DOI 10.1016/j.ddtec.2004.10.002, PII S174067490400037X
    • A. Rostami-Hodjegan and G. Tucker, " "In silico" simulations to assess the "in vivo" consequences of "in vitro" metabolic dru-drug interactions", Drug Discovery Today: Technologies, vol. 1, 2004, pp. 441-448. (Pubitemid 40186348)
    • (2004) Drug Discovery Today: Technologies , vol.1 , Issue.4 , pp. 441-448
    • Rostami-Hodjegan, A.1    Tucker, G.2
  • 16
    • 0037364162 scopus 로고    scopus 로고
    • ADMET in silico modelling: Towards prediction paradise?
    • DOI 10.1038/nrd1032
    • H. van de Waterbeemd and E. Gifford, "ADMET in silico modelling: towards prediction paradise?" Nat Rev Drug Discov, vol. 2, 2003, pp. 192-204. (Pubitemid 37361664)
    • (2003) Nature Reviews Drug Discovery , vol.2 , Issue.3 , pp. 192-204
    • Van De, W.H.1    Gifford, E.2
  • 17
    • 77954051808 scopus 로고    scopus 로고
    • National Institute of Science and Technology
    • P. Mell and T. Grance. The NIST Definition of Cloud Computing. National Institute of Science and Technology. http://csrc.nist.gov/publications/nistpubs/ 800-145/SP800-145.pdf
    • The NIST Definition of Cloud Computing
    • Mell, P.1    Grance, T.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.